Subgroup analysis methods for time-to-event outcomes in heterogeneous randomized controlled trials

Valentine Perrin,Nathan Noiry,Nicolas Loiseau,Alex Nowak

2024-01-22

Abstract:Non-significant randomized control trials can hide subgroups of good responders to experimental drugs, thus hindering subsequent development. Identifying such heterogeneous treatment effects is key for precision medicine and many post-hoc analysis methods have been developed for that purpose. While several benchmarks have been carried out to identify the strengths and weaknesses of these methods, notably for binary and continuous endpoints, similar systematic empirical evaluation of subgroup analysis for time-to-event endpoints are lacking. This work aims to fill this gap by evaluating several subgroup analysis algorithms in the context of time-to-event outcomes, by means of three different research questions: Is there heterogeneity? What are the biomarkers responsible for such heterogeneity? Who are the good responders to treatment? In this context, we propose a new synthetic and semi-synthetic data generation process that allows one to explore a wide range of heterogeneity scenarios with precise control on the level of heterogeneity. We provide an open source Python package, available on Github, containing our generation process and our comprehensive benchmark framework. We hope this package will be useful to the research community for future investigations of heterogeneity of treatment effects and subgroup analysis methods benchmarking.

Machine Learning,Applications,Methodology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how to identify subgroups that respond well to experimental drugs in heterogeneous randomized controlled trials, so as to promote the development of precision medicine. Specifically, the paper focuses on evaluating the effectiveness of several subgroup analysis algorithms in the context of time - to - event outcomes (such as survival time in survival analysis), and explores through three research questions: 1. Is there heterogeneity? 2. Which biomarkers cause this heterogeneity? 3. Who are the individuals that respond well to the treatment? To answer these questions, the authors propose a new synthetic data generation process that can precisely control the level of heterogeneity, and develop an open - source Python package `hte` for generating data and conducting a comprehensive benchmarking framework. This will help future researchers further explore the evaluation of treatment - effect heterogeneity and subgroup analysis methods.

Subgroup analysis methods for time-to-event outcomes in heterogeneous randomized controlled trials

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Identifying treatment response subgroups in observational time-to-event data

Recovering Sparse and Interpretable Subgroups with Heterogeneous Treatment Effects with Censored Time-to-Event Outcomes

Exploring Heterogeneity in Clinical Trials with Latent Class Analysis

BLAST: Bayesian Latent Subgroup Design for Basket Trials Accounting for Patient Heterogeneity

Efficient Targeted Learning of Heterogeneous Treatment Effects for Multiple Subgroups

Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials

A Utility-Based Design for Randomized Comparative Trials with Ordinal Outcomes and Prognostic Subgroups

Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint

Subgroup-Based Adaptive (SUBA) Designs for Multi-arm Biomarker Trials

Estimating the treatment effect in a subgroup defined by an early post-baseline biomarker measurement in randomized clinical trials with time-to-event endpoint

Comparing Approaches to Treatment Effect Estimation for Subgroups in Clinical Trials

Targeted Estimation of Heterogeneous Treatment Effect in Observational Survival Analysis

Estimating Interpretable Heterogeneous Treatment Effect with Causal Subgroup Discovery in Survival Outcomes

Identifying Heterogeneous Treatment Effects in Multiple Outcomes using Joint Confidence Intervals

Identification and inference for subgroups with differential treatment efficacy from randomized controlled trials with survival outcomes through multiple testing

Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials

Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data

Testing for a treatment effect in a selected subgroup

Investigating Stability in Subgroup Identification for Stratified Medicine